Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (441-450 of 528) with videos related to

Pageof 53
Sort By:
Human Genetics|August 28, 2012
A genome-wide association study of breast cancer in women of African ancestryFang Chen, Gary K Chen, Daniel O Stram, et al.
Journal of the National Cancer Institute|March 26, 2021
Evaluating Polygenic Risk Scores for Breast Cancer in Women of African AncestryZhaohui Du, Guimin Gao, Babatunde Adedokun, et al.
Human Molecular Genetics|May 13, 2022
Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approachGuimin Gao, Fangyuan Zhao, Thomas U Ahearn, et al.
Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.
The New England Journal of Medicine|January 20, 2021
A Population-Based Study of Genes Previously Implicated in Breast CancerChunling Hu, Steven N Hart, Rohan Gnanaolivu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersChristoph Engel, Beatrix Versmold, Barbara Wappenschmidt, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Nature Genetics|September 10, 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemiaSohela Shah, Kasmintan A Schrader, Esmé Waanders, et al.
Nature Communications|July 8, 2021
Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry womenBabatunde Adedokun, Zhaohui Du, Guimin Gao, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Pageof 53

Showing results (441-450 of 528) with videos related to

Sort By:
Pageof 53
Human Genetics|August 28, 2012
A genome-wide association study of breast cancer in women of African ancestryFang Chen, Gary K Chen, Daniel O Stram, et al.
Journal of the National Cancer Institute|March 26, 2021
Evaluating Polygenic Risk Scores for Breast Cancer in Women of African AncestryZhaohui Du, Guimin Gao, Babatunde Adedokun, et al.
Human Molecular Genetics|May 13, 2022
Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approachGuimin Gao, Fangyuan Zhao, Thomas U Ahearn, et al.
Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.
The New England Journal of Medicine|January 20, 2021
A Population-Based Study of Genes Previously Implicated in Breast CancerChunling Hu, Steven N Hart, Rohan Gnanaolivu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersChristoph Engel, Beatrix Versmold, Barbara Wappenschmidt, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Nature Genetics|September 10, 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemiaSohela Shah, Kasmintan A Schrader, Esmé Waanders, et al.
Nature Communications|July 8, 2021
Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry womenBabatunde Adedokun, Zhaohui Du, Guimin Gao, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Pageof 53